Darunavir Impurity 4 NEW

Darunavir Impurity 4;1291087-81-4

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• Product Information

• Product Code: D034004

• English Name: Darunavir Impurity 4

• English Alias: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-(((((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)oxy)-1-phenylbutan-2-yl)carbamate

• CAS No.：1291087-81-4

• Molecular Formula: C₃₄H₄₅N₃O₁₁S

• Molecular Weight: 703.80

• Advantages

• As an important impurity of Darunavir, this compound features a clear structure and controllable purity. It is applicable for the qualitative and quantitative analysis of impurities in the drug research and development process, ensuring the quality, safety, and consistency of the main drug, and providing key references for pharmaceutical quality control.

• Applications

• It is mainly used in the research, quality study, and stability investigation of Darunavir-related drugs. As a reference standard, it can be used for the establishment and validation of detection methods such as chromatographic analysis (e.g., HPLC, LC-MS) and spectral analysis. It can also be used to evaluate the generation and control level of impurities in the pharmaceutical production process.

• Background Description

• Darunavir is a protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection, with wide clinical application. The generation of impurities is inevitable during drug synthesis and storage, and the presence of impurities may affect the efficacy and safety of the drug. Therefore, the study of Darunavir impurities is an important part of the drug quality control system. The research on the structure and properties of Darunavir Impurity 4, as a specific impurity, is of great significance for ensuring drug quality.

• Research Status

• At present, the research on this impurity mainly focuses on the development of analytical methods, toxicity assessment, and optimization of synthetic routes. Researchers have established quantitative analytical methods for this impurity through efficient separation technologies and precise detection means. Meanwhile, by simulating the drug production process, the formation mechanism of this impurity is explored to optimize the production process and reduce its generation. In addition, the interaction between this impurity and the main drug and its potential impact on drug efficacy are also under further study.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!